Author: Peter Mansell

Industry-funded studies win on impact factor

Clinical studies sponsored by the pharmaceutical industry are far more likely to find their way into prestigious and high-impact journals than those supported by government or private funding, researchers in Italy have found.

Read More

etrials “could become profitable” in 2009

Next year could see a return to profit for etrials Worldwide, the troubled US-based supplier of adaptive eClinical software and services, believes the company’s president and chief executive officer (CEO), Denis Connaghan.

Read More

WIL Research rounds out offering with Midwest BioResearch

US-based contract research organisation (CRO) WIL Research Laboratories and WIL Research Holding Company, which took over the CRO in a management buyout in September 2004, have acquired MidWest BioResearch, a US provider of drug disposition and toxicology services, for an undisclosed sum.

Read More